0001127602-20-018895.txt : 20200604
0001127602-20-018895.hdr.sgml : 20200604
20200604184150
ACCESSION NUMBER: 0001127602-20-018895
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200513
FILED AS OF DATE: 20200604
DATE AS OF CHANGE: 20200604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andres Juan
CENTRAL INDEX KEY: 0001760670
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 20944052
MAIL ADDRESS:
STREET 1: C/O MODERNA, INC.
STREET 2: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2020-05-13
2020-05-14
0001682852
Moderna, Inc.
MRNA
0001760670
Andres Juan
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
See remarks
Common Stock
2020-05-13
4
S
0
1300
66.89
D
0
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.88 to $66.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This amendment is being filed to revise footnote 1 included in the original Form 4 referenced herein to read as set forth in footnote 1 above. The transaction described in Table I of this filing is not new or revised, but is being reported again to gain access to the EDGAR reporting system.
/s/ Lori Henderson, as Attorney-in-Fact
2020-06-04